Krilogy Financial LLC Makes New $995,000 Investment in CME Group Inc. $CME

Krilogy Financial LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,711 shares of the financial services provider’s stock, valued at approximately $995,000.

A number of other large investors also recently bought and sold shares of CME. Vanguard Group Inc. lifted its holdings in CME Group by 1.5% during the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after purchasing an additional 532,549 shares in the last quarter. Geode Capital Management LLC boosted its stake in CME Group by 3.6% during the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after purchasing an additional 319,899 shares during the last quarter. Norges Bank purchased a new position in shares of CME Group in the second quarter worth about $1,571,447,000. Ameriprise Financial Inc. grew its stake in CME Group by 2.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after acquiring an additional 92,925 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of CME Group by 6.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock worth $1,056,476,000 after purchasing an additional 238,522 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Company raised cash returns — declared a Q1 regular dividend of $1.30 per share (4% increase) and an annual variable dividend of $6.15 per share (~$2.2B), both payable March 26 to holders of record March 10; this boosts income yield and signals strong 2025 free cash flow. Dividend Release
• Positive Sentiment: New product pipeline: CME is exploring a first-ever rare-earths futures contract and has been reported to be planning launches that could create transparent price benchmarks for strategically important commodities — potential long-term revenue driver. Rare-Earths/Expansion Reporting
• Positive Sentiment: Asia expansion: Reuters reports CME plans to list Taiwan and Hong Kong warehouses as part of an Asia aluminium push — this regional expansion could deepen physical-derivatives liquidity and fee pools. Asia Warehouses Story
• Positive Sentiment: Product traction in digital assets: CME announced first trades in new Cardano, Chainlink and Stellar futures — incremental product diversification and fee generation from crypto derivatives. Crypto Futures Release
• Positive Sentiment: Institutional demand: Illinois Municipal Retirement Fund disclosed a material addition to its CME position (~38,147 shares), a sign of institutional buying interest. QuiverQuant Fund Update
• Positive Sentiment: Volume catalysts: Wedbush highlighted surging volumes in CME’s prediction markets around Super Bowl LX, underscoring episodic volume drivers for clearing revenues. Wedbush Note
• Neutral Sentiment: Board slate: CME filed its slate of director nominees for the May annual meeting — routine governance update with limited near-term price impact. Director Nominees Release
• Neutral Sentiment: Short-interest data appears anomalous (reports showing 0 shares and NaN changes) — no clear evidence of elevated short activity from the available reports. Short Interest Reports
• Negative Sentiment: Sell-side signal: Goldman Sachs raised its price target but to $266 — notably below current levels — which could be interpreted as a conservative view on near-term upside and may weigh on sentiment. Goldman Sachs Note

Insiders Place Their Bets

In other news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William R. Shepard purchased 251 shares of the business’s stock in a transaction that occurred on Tuesday, December 30th. The shares were bought at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares in the company, valued at $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have issued reports on CME shares. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of CME Group in a research note on Monday, December 29th. Argus dropped their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Morgan Stanley boosted their target price on CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft raised their price target on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, Barclays boosted their price objective on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $297.59.

CME Group Price Performance

CME stock opened at $301.64 on Friday. The business’s 50-day moving average is $279.18 and its two-hundred day moving average is $273.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. The firm has a market capitalization of $108.77 billion, a P/E ratio of 27.03, a P/E/G ratio of 3.29 and a beta of 0.27. CME Group Inc. has a 1 year low of $244.43 and a 1 year high of $309.35.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $2.52 earnings per share. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Tuesday, March 10th. CME Group’s payout ratio is 44.80%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.